| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.24B | +41.5% |
| Cost of Revenue | $1.92B | +47.1% |
| R&D Expense | $332.9M | +51.2% |
| SG&A Expense | $977.3M | +22.6% |
| Operating Income | -$474.8M | -246.4% |
| Interest Expense | $110.2M | +221.5% |
| Pre-tax Income | -$1.53B | -309.1% |
| Income Tax | -$331.1M | -338.2% |
| Net Income | -$1.17B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.42B | -33.1% |
| Short-term Investments | $239.4M | +1109.7% |
| Accounts Receivable | $607.8M | -12.3% |
| Current Assets | $2.56B | -16.7% |
| Total Assets | $10.39B | -15.5% |
| Current Liabilities | $1.08B | -21.7% |
| Long-term Debt | $2.07B | -1.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $139.8M | +54.9% |
| -295.8% |
| EPS (Basic) | -$13.55 | -302.2% |
| EPS (Diluted) | -$13.55 | -314.7% |
| Stockholders' Equity |
| $5.93B |
| -17.3% |